Report Detail

Request for Sample of this report

Pharma & Healthcare Global Active Hemostatic Agents Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4521290
    • |
  • 14 March, 2023
    • |
  • Global
    • |
  • 112 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Active Hemostatic Agents market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Active hemostatic agents are standard surgical techniques to manage bleeding from surgical surfaces. Active hemostatic agents are used in a wide variety of surgical settings, and the evolution of this class of surgical tools helps in the progress of active hemostats into present-day surgery and urology, and highlight opportunities for future research.
This report is a detailed and comprehensive analysis for global Active Hemostatic Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Active Hemostatic Agents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Active Hemostatic Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Active Hemostatic Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Active Hemostatic Agents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Active Hemostatic Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Active Hemostatic Agents market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic Plc., Ethicon Inc., Pfizer Inc., Baxter International Inc. and CryoLife Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Active Hemostatic Agents market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Thrombin based hemostats
Surgical Sealants
Combination Products
Market segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Major players covered
Medtronic Plc.
Ethicon Inc.
Pfizer Inc.
Baxter International Inc.
CryoLife Inc.
Integra Life Sciences Corporation, etc.
Stryker
Biom’up
BD
Johnson & Johnson Services
C.R.Bard
B. Braun Melsungen AG
Z-Medica LLC
Advanced Medical Solutions Group plc
GELITA GA
Active Hemostatic Agents
Warrior Tactical, LLC
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Active Hemostatic Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Active Hemostatic Agents, with price, sales, revenue and global market share of Active Hemostatic Agents from 2018 to 2023.
Chapter 3, the Active Hemostatic Agents competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Active Hemostatic Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Active Hemostatic Agents market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Active Hemostatic Agents.
Chapter 14 and 15, to describe Active Hemostatic Agents sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Active Hemostatic Agents
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Active Hemostatic Agents Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Thrombin based hemostats
    • 1.3.3 Surgical Sealants
    • 1.3.4 Combination Products
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Active Hemostatic Agents Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals
    • 1.4.3 Ambulatory Surgical Centers
    • 1.4.4 Specialty Clinics
  • 1.5 Global Active Hemostatic Agents Market Size & Forecast
    • 1.5.1 Global Active Hemostatic Agents Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Active Hemostatic Agents Sales Quantity (2018-2029)
    • 1.5.3 Global Active Hemostatic Agents Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Medtronic Plc.
    • 2.1.1 Medtronic Plc. Details
    • 2.1.2 Medtronic Plc. Major Business
    • 2.1.3 Medtronic Plc. Active Hemostatic Agents Product and Services
    • 2.1.4 Medtronic Plc. Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Medtronic Plc. Recent Developments/Updates
  • 2.2 Ethicon Inc.
    • 2.2.1 Ethicon Inc. Details
    • 2.2.2 Ethicon Inc. Major Business
    • 2.2.3 Ethicon Inc. Active Hemostatic Agents Product and Services
    • 2.2.4 Ethicon Inc. Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Ethicon Inc. Recent Developments/Updates
  • 2.3 Pfizer Inc.
    • 2.3.1 Pfizer Inc. Details
    • 2.3.2 Pfizer Inc. Major Business
    • 2.3.3 Pfizer Inc. Active Hemostatic Agents Product and Services
    • 2.3.4 Pfizer Inc. Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Pfizer Inc. Recent Developments/Updates
  • 2.4 Baxter International Inc.
    • 2.4.1 Baxter International Inc. Details
    • 2.4.2 Baxter International Inc. Major Business
    • 2.4.3 Baxter International Inc. Active Hemostatic Agents Product and Services
    • 2.4.4 Baxter International Inc. Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Baxter International Inc. Recent Developments/Updates
  • 2.5 CryoLife Inc.
    • 2.5.1 CryoLife Inc. Details
    • 2.5.2 CryoLife Inc. Major Business
    • 2.5.3 CryoLife Inc. Active Hemostatic Agents Product and Services
    • 2.5.4 CryoLife Inc. Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 CryoLife Inc. Recent Developments/Updates
  • 2.6 Integra Life Sciences Corporation, etc.
    • 2.6.1 Integra Life Sciences Corporation, etc. Details
    • 2.6.2 Integra Life Sciences Corporation, etc. Major Business
    • 2.6.3 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Product and Services
    • 2.6.4 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Integra Life Sciences Corporation, etc. Recent Developments/Updates
  • 2.7 Stryker
    • 2.7.1 Stryker Details
    • 2.7.2 Stryker Major Business
    • 2.7.3 Stryker Active Hemostatic Agents Product and Services
    • 2.7.4 Stryker Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Stryker Recent Developments/Updates
  • 2.8 Biom’up
    • 2.8.1 Biom’up Details
    • 2.8.2 Biom’up Major Business
    • 2.8.3 Biom’up Active Hemostatic Agents Product and Services
    • 2.8.4 Biom’up Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Biom’up Recent Developments/Updates
  • 2.9 BD
    • 2.9.1 BD Details
    • 2.9.2 BD Major Business
    • 2.9.3 BD Active Hemostatic Agents Product and Services
    • 2.9.4 BD Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 BD Recent Developments/Updates
  • 2.10 Johnson & Johnson Services
    • 2.10.1 Johnson & Johnson Services Details
    • 2.10.2 Johnson & Johnson Services Major Business
    • 2.10.3 Johnson & Johnson Services Active Hemostatic Agents Product and Services
    • 2.10.4 Johnson & Johnson Services Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Johnson & Johnson Services Recent Developments/Updates
  • 2.11 C.R.Bard
    • 2.11.1 C.R.Bard Details
    • 2.11.2 C.R.Bard Major Business
    • 2.11.3 C.R.Bard Active Hemostatic Agents Product and Services
    • 2.11.4 C.R.Bard Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 C.R.Bard Recent Developments/Updates
  • 2.12 B. Braun Melsungen AG
    • 2.12.1 B. Braun Melsungen AG Details
    • 2.12.2 B. Braun Melsungen AG Major Business
    • 2.12.3 B. Braun Melsungen AG Active Hemostatic Agents Product and Services
    • 2.12.4 B. Braun Melsungen AG Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 B. Braun Melsungen AG Recent Developments/Updates
  • 2.13 Z-Medica LLC
    • 2.13.1 Z-Medica LLC Details
    • 2.13.2 Z-Medica LLC Major Business
    • 2.13.3 Z-Medica LLC Active Hemostatic Agents Product and Services
    • 2.13.4 Z-Medica LLC Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Z-Medica LLC Recent Developments/Updates
  • 2.14 Advanced Medical Solutions Group plc
    • 2.14.1 Advanced Medical Solutions Group plc Details
    • 2.14.2 Advanced Medical Solutions Group plc Major Business
    • 2.14.3 Advanced Medical Solutions Group plc Active Hemostatic Agents Product and Services
    • 2.14.4 Advanced Medical Solutions Group plc Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Advanced Medical Solutions Group plc Recent Developments/Updates
  • 2.15 GELITA GA
    • 2.15.1 GELITA GA Details
    • 2.15.2 GELITA GA Major Business
    • 2.15.3 GELITA GA Active Hemostatic Agents Product and Services
    • 2.15.4 GELITA GA Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 GELITA GA Recent Developments/Updates
  • 2.16 Active Hemostatic Agents
    • 2.16.1 Active Hemostatic Agents Details
    • 2.16.2 Active Hemostatic Agents Major Business
    • 2.16.3 Active Hemostatic Agents Active Hemostatic Agents Product and Services
    • 2.16.4 Active Hemostatic Agents Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Active Hemostatic Agents Recent Developments/Updates
  • 2.17 Warrior Tactical, LLC
    • 2.17.1 Warrior Tactical, LLC Details
    • 2.17.2 Warrior Tactical, LLC Major Business
    • 2.17.3 Warrior Tactical, LLC Active Hemostatic Agents Product and Services
    • 2.17.4 Warrior Tactical, LLC Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Warrior Tactical, LLC Recent Developments/Updates

3 Competitive Environment: Active Hemostatic Agents by Manufacturer

  • 3.1 Global Active Hemostatic Agents Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Active Hemostatic Agents Revenue by Manufacturer (2018-2023)
  • 3.3 Global Active Hemostatic Agents Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Active Hemostatic Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Active Hemostatic Agents Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Active Hemostatic Agents Manufacturer Market Share in 2022
  • 3.5 Active Hemostatic Agents Market: Overall Company Footprint Analysis
    • 3.5.1 Active Hemostatic Agents Market: Region Footprint
    • 3.5.2 Active Hemostatic Agents Market: Company Product Type Footprint
    • 3.5.3 Active Hemostatic Agents Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Active Hemostatic Agents Market Size by Region
    • 4.1.1 Global Active Hemostatic Agents Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Active Hemostatic Agents Consumption Value by Region (2018-2029)
    • 4.1.3 Global Active Hemostatic Agents Average Price by Region (2018-2029)
  • 4.2 North America Active Hemostatic Agents Consumption Value (2018-2029)
  • 4.3 Europe Active Hemostatic Agents Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Active Hemostatic Agents Consumption Value (2018-2029)
  • 4.5 South America Active Hemostatic Agents Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Active Hemostatic Agents Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Active Hemostatic Agents Sales Quantity by Type (2018-2029)
  • 5.2 Global Active Hemostatic Agents Consumption Value by Type (2018-2029)
  • 5.3 Global Active Hemostatic Agents Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Active Hemostatic Agents Sales Quantity by Application (2018-2029)
  • 6.2 Global Active Hemostatic Agents Consumption Value by Application (2018-2029)
  • 6.3 Global Active Hemostatic Agents Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Active Hemostatic Agents Sales Quantity by Type (2018-2029)
  • 7.2 North America Active Hemostatic Agents Sales Quantity by Application (2018-2029)
  • 7.3 North America Active Hemostatic Agents Market Size by Country
    • 7.3.1 North America Active Hemostatic Agents Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Active Hemostatic Agents Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Active Hemostatic Agents Sales Quantity by Type (2018-2029)
  • 8.2 Europe Active Hemostatic Agents Sales Quantity by Application (2018-2029)
  • 8.3 Europe Active Hemostatic Agents Market Size by Country
    • 8.3.1 Europe Active Hemostatic Agents Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Active Hemostatic Agents Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Active Hemostatic Agents Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Active Hemostatic Agents Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Active Hemostatic Agents Market Size by Region
    • 9.3.1 Asia-Pacific Active Hemostatic Agents Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Active Hemostatic Agents Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Active Hemostatic Agents Sales Quantity by Type (2018-2029)
  • 10.2 South America Active Hemostatic Agents Sales Quantity by Application (2018-2029)
  • 10.3 South America Active Hemostatic Agents Market Size by Country
    • 10.3.1 South America Active Hemostatic Agents Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Active Hemostatic Agents Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Active Hemostatic Agents Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Active Hemostatic Agents Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Active Hemostatic Agents Market Size by Country
    • 11.3.1 Middle East & Africa Active Hemostatic Agents Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Active Hemostatic Agents Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Active Hemostatic Agents Market Drivers
  • 12.2 Active Hemostatic Agents Market Restraints
  • 12.3 Active Hemostatic Agents Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Active Hemostatic Agents and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Active Hemostatic Agents
  • 13.3 Active Hemostatic Agents Production Process
  • 13.4 Active Hemostatic Agents Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Active Hemostatic Agents Typical Distributors
  • 14.3 Active Hemostatic Agents Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Active Hemostatic Agents. Industry analysis & Market Report on Active Hemostatic Agents is a syndicated market report, published as Global Active Hemostatic Agents Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Active Hemostatic Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,742.24
    		4,113.36
    		5,484.48
    		3,201.60
    		4,802.40
    		6,403.20
    		541,557.60
    		812,336.40
    		1,083,115.20
    		290,162.40
    		435,243.60
    		580,324.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo